Best Cytoreductive Surgery (CRS) & HIPEC Treatment in Delhi

Peritoneal Surface Malignancies (PSM) are a group of cancers that spread to the lining of the abdominal cavity, known as the peritoneum. These cancers can arise from the colon, appendix, stomach, ovaries, or other abdominal organs. In the past, peritoneal cancer spread was often considered incurable. However, advances in cancer treatment have transformed outcomes for many patients through specialized procedures such as Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

For patients seeking the best CRS and HIPEC treatment in Delhi, expert care and timely intervention can significantly improve survival and quality of life.

Table of Contents

• What is Peritoneal Surface Malignancy (PSM)?

• What is Cytoreductive Surgery (CRS)?

• What is HIPEC?

• Conditions Treated with CRS and HIPEC

• Symptoms of Peritoneal Surface Malignancies

• Best CRS and HIPEC Treatment in Delhi

• Advanced Treatment Options Available

• Cytoreductive Surgery (CRS)

• HIPEC Treatment

• Systemic Chemotherapy

• Targeted Therapy and Immunotherapy

• CRS and HIPEC Treatment Cost in Delhi

• Why Choose Us for CRS and HIPEC Treatment in Delhi?

• Take the First Step Toward Recovery

What is Peritoneal Surface Malignancy (PSM)?

Peritoneal Surface Malignancy refers to cancer that has spread to the peritoneum, the thin membrane lining the abdominal cavity and covering abdominal organs. It may originate from:

• Colon Cancer

• Appendix Cancer

• Gastric (Stomach) Cancer

• Ovarian Cancer

• Pseudomyxoma Peritonei (PMP)

• Peritoneal Mesothelioma

Without specialized treatment, these cancers can cause progressive disease within the abdomen, leading to significant symptoms and reduced survival.

What is Cytoreductive Surgery (CRS)?

Cytoreductive Surgery (CRS) is an advanced surgical procedure designed to remove all visible cancer deposits from the abdominal cavity. The goal is to achieve complete tumor removal, often involving multiple abdominal organs or peritoneal surfaces when necessary.

CRS has become a cornerstone treatment for selected patients with peritoneal surface malignancies and offers the possibility of long-term disease control and, in some cases, cure.

What is HIPEC?

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a specialized treatment performed immediately after Cytoreductive Surgery.

During HIPEC:

• Heated chemotherapy is circulated throughout the abdominal cavity.

• The chemotherapy directly targets microscopic cancer cells that may remain after surgery.

• Heat enhances the effectiveness of chemotherapy while limiting systemic side effects.

The combination of CRS and HIPEC has significantly improved outcomes for many patients with peritoneal cancers.

Conditions Treated with CRS and HIPEC

CRS and HIPEC may be recommended for:

Pseudomyxoma Peritonei (PMP)

A rare condition often arising from appendix tumors that produces mucin within the abdomen.

Peritoneal Metastases from Colon Cancer

Selected patients with colon cancer spread to the peritoneum can benefit from CRS and HIPEC.

Appendix Cancer

Appendiceal tumors frequently spread within the abdominal cavity and are commonly treated with CRS and HIPEC.

Gastric Cancer with Peritoneal Spread

In carefully selected cases, CRS and HIPEC may improve outcomes.

Peritoneal Mesothelioma

A rare cancer affecting the peritoneal lining that often responds well to aggressive cytoreduction and HIPEC.

Ovarian Cancer

Selected recurrent or advanced ovarian cancer cases may benefit from CRS-based treatment approaches.

Symptoms of Peritoneal Surface Malignancies

Symptoms often develop gradually and may include:

• Abdominal bloating

• Increasing abdominal girth

• Persistent abdominal pain

• Loss of appetite

• Early satiety (feeling full quickly)

• Unexplained weight loss

• Nausea and vomiting

• Changes in bowel habits

• Fluid accumulation in the abdomen (ascites)

If these symptoms persist, specialist evaluation is essential for accurate diagnosis and treatment planning.

Best CRS and HIPEC Treatment in Delhi

Delhi is home to some of India’s leading cancer centers offering advanced peritoneal cancer treatment.

Dr. Asit Arora is an experienced GI and HPB Surgical Oncologist specializing in Cytoreductive Surgery and HIPEC procedures. His patient-centered approach focuses on comprehensive evaluation, precise surgical planning, and multidisciplinary cancer care to achieve optimal outcomes.

Advanced Treatment Options Available

Treatment is individualized based on the cancer type, extent of disease, and overall health of the patient.

Cytoreductive Surgery (CRS)

The primary treatment involves meticulous removal of all visible cancer deposits from the abdominal cavity. This may include removal of affected peritoneal surfaces and involved organs when necessary.

HIPEC Treatment

Immediately after CRS, heated chemotherapy is circulated within the abdominal cavity to eliminate microscopic residual disease and reduce recurrence risk.

Systemic Chemotherapy

Many patients benefit from chemotherapy before surgery (neoadjuvant) or after surgery (adjuvant) to improve outcomes.

Targeted Therapy and Immunotherapy

For selected cancers, molecularly targeted therapies and immunotherapy can be integrated into the treatment plan based on tumor biology.

CRS and HIPEC Treatment Cost in Delhi

The cost of CRS and HIPEC treatment depends on several factors, including:

• Extent of disease

• Complexity of surgery

• Duration of hospitalization

• ICU requirements

• Chemotherapy medications used during HIPEC

• Additional systemic treatments

General estimates include:

• Cytoreductive Surgery (CRS): ₹4,00,000 to ₹12,00,000+

• HIPEC Procedure: Additional ₹2,00,000 to ₹5,00,000+

• Chemotherapy and supportive treatments: Variable depending on treatment protocol

Most major hospitals offer insurance support and financial counseling services to assist patients throughout their treatment journey.

Why Choose Us for CRS and HIPEC Treatment in Delhi?

When dealing with complex peritoneal cancers, experience and specialized expertise are critical.

Expertise You Can Trust

Dr. Asit Arora has extensive experience in managing advanced gastrointestinal and peritoneal malignancies, including CRS and HIPEC procedures.

Comprehensive Personalized Care

Every patient receives a tailored treatment plan based on detailed clinical evaluation and tumor characteristics.

Multidisciplinary Cancer Care

Our team includes surgical oncologists, medical oncologists, radiologists, pathologists, anesthesiologists, and critical care specialists working together to deliver optimal outcomes.

Advanced Surgical Technology

We utilize modern surgical techniques, advanced imaging, and evidence-based treatment protocols to maximize treatment success.

Dedicated Patient Support

From diagnosis through recovery and long-term follow-up, our team remains committed to supporting patients and their families every step of the way.

Take the First Step Toward Recovery

A diagnosis of peritoneal surface malignancy can feel overwhelming, but advanced treatments such as Cytoreductive Surgery and HIPEC have created new hope for many patients.

Dr. Asit Arora and his team are dedicated to providing world-class CRS and HIPEC treatment in Delhi, helping patients achieve the best possible outcomes through personalized, evidence-based care.

Schedule a consultation today to explore your treatment options and take the first step toward recovery.